Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Relief of dyspnea with high-flow nasal therapy in palliative care

Official title: Management of Dyspnea With High- Flow Nasal Therapy

Run by Tampere University Hospital · NCT07552935 · Data updated 2026-11-12

This study tests whether high-flow nasal therapy helps relieve breathlessness in adults receiving palliative care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorTampere University Hospital
Academic / other
Locations2 sites (Tampere and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedJune 30, 2026
Trial IDNCT07552935 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) in palliative care with significant dyspnea (NRS ≥ 4) who are not expected to benefit from ICU-level or invasive ventilation.

Probably not a fit

Patients with inability to tolerate HFNT, delirium or inability to consent, or dyspnea caused by conditions immediately treatable by other means may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In adults with incurable illnesses, severe dyspnea can greatly reduce quality of life. This trial examines high-flow nasal therapy (HFNT) delivered via a nasal cannula, with airflow directed toward the face as a potential option for comfort. Participants receive HFNT and face-directed airflow, and feasibility and relief of dyspnea are assessed in palliative care settings. The study targets 30–40 patients recruited from the Hatanpää Palliative Care Ward and Pirkanmaa Hospice in Tampere, Finland. Eligibility requires age 18+, significant dyspnea (NRS ≥ 4), and informed consent.

Why it matters

Potential benefit: If successful, HFNT could become a feasible modality to lessen breathlessness and improve comfort for patients in palliative care.

How similar studies have gone: HFNT has shown signal of dyspnea relief in cancer patients, but its use in hospice/palliative settings is not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The patient is in palliative care (ICD-10 diagnostic code Z51.5 palliative care)
* Age ≥ 18 years
* Ability to understand the study and provide informed consent to participate
* Significant breathlessness (NRS = Numeric Rating Scale ≥ 4).
* The treating physician has assessed that the patient would not benefit from treatment in intensive care unit or monitor unit.
* The treating physician has assessed that the patient would not benefit from invasive mechanical ventilation (intubation) or cardiopulmonary resuscitation.

Exclusion Criteria:

* Decreased level of consciousness, delirium, or other lack of cooperation that prevents participation.
* Respiratory support other than HFNT is required.
* The patient has received HFNT during the same admission to palliative care ward or hospice.
* The cause of dyspnea can be treated immediately.
* Inability to provide informed consent to participate.

Where it's running

  • Pirkanmaa Hospice
    Tampere, Finland
    Recruiting
  • Hatanpää hospital, Palliative Care Centre and Home Hospital Services, Wellbeing Services County of Pirkanmaa, Tampere University Hospital
    Tampere, Finland
    Recruiting

Study contacts

  • Principal investigator: Juho Lehto, Professor — Tampere University Hospital and Tampere University, Tampere, Finland.
  • Study coordinator: Juho Lehto, Professor
  • Email: juho.lehto@tuni.fi
  • Phone: +358 50 4090974

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.